These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6615107)

  • 1. Prolongation of the prodrome to acute hepatitis B infection by corticosteroids.
    Johnson BE; Reed JS
    Arch Intern Med; 1983 Sep; 143(9):1810-1. PubMed ID: 6615107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombocytopenia complicating infectious hepatitis.
    Laursen HB
    Acta Hepatogastroenterol (Stuttg); 1975 Apr; 22(2):102-5. PubMed ID: 1130162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum sickness and hepatitis B vaccine including review of the literature.
    Arkachaisri T
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S607-12. PubMed ID: 12403239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan.
    Suzuki Y; Kobayashi M; Ikeda K; Suzuki F; Arfase Y; Akuta N; Hosaka T; Saitoh S; Kobayashi M; Someya T; Matsuda M; Sato J; Watabiki S; Miyakawa Y; Kumada H
    J Med Virol; 2005 May; 76(1):33-9. PubMed ID: 15779048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Course of chronic virus hepatitis B in children and attempts at modifying its treatment].
    Kowalik-Mikołajewska B
    Pol Tyg Lek; 1993 Mar 15-29; 48(11-13):258-60. PubMed ID: 7694262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Besides the liver, what does the virus of hepatitis attack?
    Alpert E; Jackson D
    Heart Lung; 1982; 11(2):177-80. PubMed ID: 6916753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis.
    Rakela J; Redeker AG; Weliky B
    Gastroenterology; 1983 May; 84(5 Pt 1):956-60. PubMed ID: 6832570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A 40-year-old female patient with seronegative autoimmune hepatitis following a newly acquired hepatitis B infection].
    Zizer E; Hasel C; Seufferlein T; Adler G; Dikopoulos N
    Z Gastroenterol; 2008 Feb; 46(2):201-5. PubMed ID: 18253899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
    Ben-Ari Z; Mor E; Shapira Z; Tur-Kaspa R
    Liver Transpl; 2001 Feb; 7(2):113-7. PubMed ID: 11172394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The extrahepatic manifestations of hepatitis B virus.
    Baig S; Alamgir M
    J Coll Physicians Surg Pak; 2008 Jul; 18(7):451-7. PubMed ID: 18760074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.
    Scullard GH; Smith CI; Merigan TC; Robinson WS; Gregory PB
    Gastroenterology; 1981 Dec; 81(6):987-91. PubMed ID: 7286593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-Associated Hemophagocytic Syndrome related to acute CMV and HBV sexual co-infection: a case report.
    Halfon P; Retornaz F; Mathieu D; Helbert T; Philibert P; Pégliasco H
    J Clin Virol; 2009 Oct; 46(2):189-91. PubMed ID: 19640781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lamivudine therapy in patients with severe acute hepatitis B].
    Roznovský L; Orságová I; Kloudová A; Mrázek J
    Klin Mikrobiol Infekc Lek; 2007 Apr; 13(2):59-65. PubMed ID: 17599294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection.
    Ahmed A; Keeffe EB
    Am J Gastroenterol; 1999 Jan; 94(1):249-51. PubMed ID: 9934765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunosuppressive treatment of patients with chronic active HBsAg positive hepatitis].
    Tanno H; Fay O; Roldán L; Vorovioff J
    Acta Gastroenterol Latinoam; 1982; 12(4):323-32. PubMed ID: 7185230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy.
    Hui CK; Cheung WW; Zhang HY; Au WY; Yueng YH; Leung AY; Leung N; Luk JM; Lie AK; Kwong YL; Liang R; Lau GK
    Gastroenterology; 2006 Jul; 131(1):59-68. PubMed ID: 16831590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus reactivation after a resolutive acute hepatitis leading to a diagnosis of T cell lymphoma.
    Negreanu L; Baty G; Dubois F; de Muret A; Bacq Y
    Dig Liver Dis; 2009 Jul; 41(7):e39-41. PubMed ID: 18819852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamivudine treatment for reverse seroconversion of hepatitis B 4 years after allogeneic bone marrow transplantation.
    Hashino S; Nozawa A; Izumiyama K; Yonezumi M; Chiba K; Kondo T; Suzuki S; Hige S; Asaka M
    Bone Marrow Transplant; 2002 Feb; 29(4):361-3. PubMed ID: 11896435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome.
    Schiano TD; Te HS; Thomas RM; Hussain H; Bond K; Black M
    Am J Gastroenterol; 2001 Oct; 96(10):2984-91. PubMed ID: 11693337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamivudine treatment of advanced and decompensated liver disease due to hepatitis B.
    Van Thiel DH; Friedlander L; Kania RJ; Molloy PJ; Hassanein T; Wahlstrom E; Faruki H
    Hepatogastroenterology; 1997; 44(15):808-12. PubMed ID: 9222695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.